Craniopharyngioma With Tumoral Hemorrhage

Tongji Hospital

Status

Completed

Conditions

Apoplexy

Craniopharyngioma

Treatments

Other: intratumoral hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT04937335

kaishu1

Details and patient eligibility

About

Clinical data of 185 consecutive patients receiving resective operation with a pathological diagnosis of craniopharyngioma in our hospital between January 2013 and February 2021 were collected. Among these patients, 18 of them were recognized as craniopharyngioma with tumoral hemorrhage during the operation.

Full description

For each case, age, gender, smoking status, alcohol intake, past history, symptoms, blood pressure, blood cell count, blood biochemical tests, coagulation tests, hormone tests, radiological results, surgical treatment and the outcome at discharge were collected. The first test result after admission and before the operation was taken for the items of blood tests with multiple times in the analysis.

Enrollment

185 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

receive resective operation with a pathological diagnosis of craniopharyngioma in our hospital
enter our hospital between January 2013 and February 2021

Exclusion criteria

have a non-craniopharyngioma or unverified pathological diagnosis at discharge
have received surgical or radiological treatment on the sellar region
receive treatment of coagulation modulation, immunosuppressive agents or chemotherapeutic drugs
combine with other clinical emergencies including acute myocardial infarction, cerebral stroke, trauma and sepsis at admission
have been diagnosed with other tumors, hematological diseases, autoimmune diseases, liver failure or renal failure